Use of four‐factor prothrombin complex concentrate for the mitigation of rivaroxaban‐induced bleeding in an emergent coronary artery bypass graft

We presented the first case of four‐factor prothrombin complex concentrate (4F‐PCC) for the alleviation of bleeding for emergent on‐pump coronary artery bypass graft (CABG) with the patient discharged by postoperative day (POD) 9 with no sequelae. Until direct antidotes are available, 4F‐PCC may pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Michael, Aguele, Cliff, Darr, Umer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412829/
https://www.ncbi.nlm.nih.gov/pubmed/28469866
http://dx.doi.org/10.1002/ccr3.790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412829/
https://www.ncbi.nlm.nih.gov/pubmed/28469866
http://dx.doi.org/10.1002/ccr3.790

Ejemplares similares